The lawsuit from GenBioPro, which makes the generic version of the drug, comes as SCOTUS action looms.
By ALICE MIRANDA OLLSTEIN
04/19/2023
The company that makes the generic version of a common abortion pill sued the FDA on Wednesday, hoping to bar the agency from rolling back access to the drug if the Supreme Court allows sweeping restrictions to take effect this week.
The challenge filed in federal court in Maryland, where the agency is headquartered, argues that if the FDA implements a court order suspending approval of the drug, mifepristone, it would be “depriving GenBioPro of its constitutional and statutory rights to market mifepristone without affording GenBioPro due process of law.”
Continued: https://www.politico.com/news/2023/04/19/abortion-pill-maker-sues-fda-to-preserve-access-00092810